Using a modeling approach, similar performance of screening for trisomy 21 could be achieved in pregnancies with, compared to those without, a vanishing twin, provided that appropriate adjustments were made to the level of PAPP‐A to account for the interval between embryonic demise and blood sampling. This evidence concerns the gene PAPPA and trisomy 21.